McDonald’s E. Coli Outbreak Could Worsen Near-Term Sales Decline
McDonald’s investors will look for signs of near-term sales disruption from the recent E. coli outbreak when it reports third-quarter results
McDonald’s investors will look for signs of near-term sales disruption from the recent E. coli outbreak when it reports third-quarter results
On Monday morning, the U.S. Food and Drug Administration (FDA) approved a blood test to screen for colorectal cancer in people who are considered to be at “average risk.”
Donanemab is a monoclonal antibody that the U.S. Food and Drug Administration (FDA) approved on Tuesday with the goal of slowing the progression of early-stage symptomatic Alzheimer’s disease.
Federal health officials have announced the recall of several lots of aloe gel and hand sanitizer due to the presence of methanol, which poses a major risk to consumers’ health.
Wall Street’s main stock indexes ticked higher, with the blue-chip Dow leading gains in thin trading ahead of crucial economic data.
FDA inspectors uncover quality control issues at Neuralink’s animal research facility.
Eli Lilly said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies.
A groundbreaking vaccination to shield newborns from RSV, or respiratory syncytial virus, may be authorized by August after decades of development.